Europe’s largest independent cannabis company
We have now launched our first range of unlicensed medical cannabis products, which are already being prescribed to patients in the UK.
EMMAC in the UK
EMMAC Life Sciences Group brings together cutting-edge scientific research with the latest innovations in medical cannabis cultivation, extraction and production.
EMMAC’s wealth of medical cannabis experience, combined with a network of supply and distribution partnerships throughout Europe and the UK, mean that we are uniquely positioned to meet the rapidly growing demand for cost-effective, consistent, premium quality medical cannabis products in the UK.
Cannabis-based products for medical use
Thanks to deep scientific expertise, rigorous process management and quality control, EMMAC ensures MHRA medical-grade quality products with the full accreditation of relevant regulatory certifications for its manufacturing, distribution and supply processes.
In partnership with leading European academic institutions including Imperial College London, EMMAC is at the forefront of research to deliver clinical data regarding the efficacy of medical cannabis for pain and the potential health benefits for patients.
At EMMAC Life Sciences Group, we control the entire lifecycle of our medical cannabis – from cultivation and extraction to production and distribution.
People & expertise
EMMAC’s board and management team comprise of seasoned industry executives and consultants. Every member brings with them a wealth of knowledge and experience – from a range of scientific, medical, technical and FMCG backgrounds.
Fill in the form below to receive the latest news and developments in medical cannabis from EMMAC